BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kato M, Wakeno M, Okugawa G, Fukuda T, Azuma J, Kinoshita T, Serretti A. No Association of TPH1 218A/C Polymorphism with Treatment Response and Intolerance to SSRIs in Japanese Patients with Major Depression. Neuropsychobiology 2007;56:167-71. [DOI: 10.1159/000119734] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zandi PP, Judy JT. The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am 2010;33:181-224. [PMID: 20159346 DOI: 10.1016/j.psc.2009.12.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
2 Busch Y, Menke A. Blood-based biomarkers predicting response to antidepressants. J Neural Transm (Vienna) 2019;126:47-63. [PMID: 29374800 DOI: 10.1007/s00702-018-1844-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
3 Lanni C, Racchi M, Govoni S. Do we need pharmacogenetics to personalize antidepressant therapy? Cell Mol Life Sci 2013;70:3327-40. [DOI: 10.1007/s00018-012-1237-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Helton SG, Lohoff FW. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders. Pharmacogenomics 2015;16:541-53. [PMID: 25916524 DOI: 10.2217/pgs.15.15] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
5 Keers R, Aitchison KJ. Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics 2014;11:101-25. [DOI: 10.1586/ern.10.186] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
6 Oestergaard S, Møldrup C. Application of pharmacogenomics to clinical problems in depression. Per Med 2009;6:501-15. [PMID: 29783310 DOI: 10.2217/pme.09.32] [Reference Citation Analysis]
7 Narasimhan S, Lohoff FW. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions. Pharmacogenomics 2012;13:441-64. [DOI: 10.2217/pgs.12.1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
8 Gonda X, Petschner P, Eszlari N, Baksa D, Edes A, Antal P, Juhasz G, Bagdy G. Genetic variants in major depressive disorder: From pathophysiology to therapy. Pharmacol Ther 2019;194:22-43. [PMID: 30189291 DOI: 10.1016/j.pharmthera.2018.09.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
9 Zhao X, Huang Y, Li D, Han C, Kan Q. Association between the TPH1 A218C polymorphism and antidepressant response: evidence from an updated ethnicity, antidepressant-specific, and ethnicity–antidepressant interaction meta-analysis. Psychiatric Genetics 2015;25:1-8. [DOI: 10.1097/ypg.0000000000000070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Fabbri C, Di Girolamo G, Serretti A. Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research. Am J Med Genet 2013;162:487-520. [DOI: 10.1002/ajmg.b.32184] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 7.4] [Reference Citation Analysis]
11 Viikki M, Kampman O, Illi A, Setälä-Soikkeli E, Anttila S, Huuhka M, Nuolivirta T, Poutanen O, Mononen N, Lehtimäki T, Leinonen E. TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett 2010;468:80-4. [PMID: 19874868 DOI: 10.1016/j.neulet.2009.10.069] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
12 El-Hage W, Leman S, Camus V, Belzung C. Mechanisms of antidepressant resistance. Front Pharmacol 2013;4:146. [PMID: 24319431 DOI: 10.3389/fphar.2013.00146] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
13 Papakostas GI, Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci 2008;10:439-51. [PMID: 19170401 [PMID: 19170401 DOI: 10.31887/dcns.2008.10.4/gipapakostas] [Cited by in Crossref: 25] [Article Influence: 2.1] [Reference Citation Analysis]
14 Fabbri C, Minarini A, Niitsu T, Serretti A. Understanding the pharmacogenetics of selective serotonin reuptake inhibitors. Expert Opin Drug Metab Toxicol 2014;10:1093-118. [PMID: 24930681 DOI: 10.1517/17425255.2014.928693] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
15 O'leary OF, O'brien FE, O'connor RM, Cryan JF. Drugs, genes and the blues: Pharmacogenetics of the antidepressant response from mouse to man. Pharmacology Biochemistry and Behavior 2014;123:55-76. [DOI: 10.1016/j.pbb.2013.10.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
16 Crisafulli C, Fabbri C, Porcelli S, Drago A, Spina E, De Ronchi D, Serretti A. Pharmacogenetics of antidepressants. Front Pharmacol 2011;2:6. [PMID: 21687501 DOI: 10.3389/fphar.2011.00006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
17 Breitenstein B, Scheuer S, Holsboer F. Are there meaningful biomarkers of treatment response for depression? Drug Discov Today 2014;19:539-61. [PMID: 24561326 DOI: 10.1016/j.drudis.2014.02.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
18 Arias B, Fabbri C, Gressier F, Serretti A, Mitjans M, Gastó C, Catalán R, De Ronchi D, Fañanás L. TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. Neuropsychobiology 2013;67:41-7. [PMID: 23221997 DOI: 10.1159/000343388] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
19 Papakostas GI. Surrogate markers of treatment outcome in major depressive disorder. Int J Neuropsychopharmacol 2012;15:841-54. [PMID: 21813045 DOI: 10.1017/S1461145711001246] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
20 Fabbri C, Porcelli S, Serretti A. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Can J Psychiatry 2014;59:62-75. [PMID: 24881125 DOI: 10.1177/070674371405900202] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
21 Kato M, Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 2010;15:473-500. [DOI: 10.1038/mp.2008.116] [Cited by in Crossref: 305] [Cited by in F6Publishing: 283] [Article Influence: 23.5] [Reference Citation Analysis]
22 Horstmann S, Binder EB. Pharmacogenomics of antidepressant drugs. Pharmacol Ther. 2009;124:57-73. [PMID: 19563827 DOI: 10.1016/j.pharmthera.2009.06.007] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 6.6] [Reference Citation Analysis]
23 Zandi PP, Judy JT. The promise and reality of pharmacogenetics in psychiatry. Clin Lab Med. 2010;30:931-974. [PMID: 20832660 DOI: 10.1016/j.cll.2010.07.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
24 Serretti A, Gibiino S, Olgiati P. Pharmacogenetics of antidepressants and mood stabilizers. Neurobiology of Psychiatric Disorders. Elsevier; 2012. pp. 715-44. [DOI: 10.1016/b978-0-444-52002-9.00043-7] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
25 Wang HC, Yeh TL, Chang HH, Gean PW, Chi MH, Yang YK, Lu RB, Chen PS. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology (Berl) 2011;213:773-9. [PMID: 20945066 DOI: 10.1007/s00213-010-2034-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
26 Niitsu T, Fabbri C, Bentini F, Serretti A. Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2013;45:183-94. [PMID: 23733030 DOI: 10.1016/j.pnpbp.2013.05.011] [Cited by in Crossref: 137] [Cited by in F6Publishing: 124] [Article Influence: 17.1] [Reference Citation Analysis]